Pharmacogenomics Startup GENETWORx Launches New Website

GENETWORx has launched a new website to highlight their drug-response DNA testing that helps patients, healthcare professionals and plan sponsors determine the right dose, of the right medication, for the best patient outcome.
 
 
GENETWORx logo
GENETWORx logo
 
Spread the Word
Listed Under

Tags:
* Pharmacogenomics
* Dna Testing
* Personalized Medicine
* Genetworx
* Scott Blevins

Industrys:
* Medical
* Science
* Technology

Location:
* Richmond - Virginia - US

Aug. 10, 2011 - PRLog -- GENETWORx, the latest player in the developing pharmacogenomics sector, launched a new site this week to feature their key to personalized medicine: DNA drug-response testing  to ensure patients get the right dose, of the right medication, right from the start, to ensure the best outcome for each individual patient. Visit http://www.genetworx.com to tour the new site.

Scott Blevins, a pharmacist with a strong business background, including an MBA from the Robins School of Business at the University of Richmond, is the founder of GENETWORx. "My experience in the technology side of healthcare, combined with my clinical knowledge, tells me that pharmacogenomics is the future of pharmacology," he says.

Blevins continued, "offering patients, doctors, pharmacists and health plan sponsors an easy, cost-effective way to determine the optimum dosage for each patient, for a large percentage of commonly-prescribed medications, will reduce over- and under-dosing. Which will in turn reduce medical costs. Everybody wins."

The enzymes tested by GENETWORx - CYP450 enzymes 2C19, 2C9 and 2D6 - show response to a number of anticoagulants, anti-convulsants, antihistamines, anti-fungals, narcotics, and other drugs. The full GENETWORx test menu is linked here (http://www.genetworx.com/testing-menu).

About GENETWORx:
Our mission is to deliver meaningful Personalized Medicine results to patients, providing health care professionals the necessary tools to leverage their knowledge and truly individualize treatment plans based on a patient’s DNA – Utilizing the latest technology in DNA sequencing to help provide the right medications, at the right dose, and effectively lower overall healthcare expenditures while delivering the best health outcome for the patient.

# # #

WellCentrix is helping healthcare communicate with its customers: patients, peers, plan sponsors, technology partners.
End
Source:GENETWORx
Email:***@wellcentrix.com Email Verified
Phone:804.467.5716
Zip:23229
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Patients for Clinical Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share